Back to results
US 12,310,949 B2Granted
Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)
AssigneePoxel
InventorsSébastien Bolze, Pascale Fouqueray, Sophie Hallakou-Bozec
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a thienopyridone derivative, or a pharmaceutical composition comprising the same, in the treatment of autosomal dominant polycystic kidney disease (ADPKD).
Claims6
A method of limiting renal cyst growth or reducing renal cyst volume in a subject having autosomal dominant polycystic kidney disease (ADPKD) comprising administering to the subject having ADPKD a compound of formula (II)
- or a pharmaceutically acceptable salt and/or solvate thereof in an amount that limits renal cyst growth or reduces renal cyst volume.
Dependencies are inferred from the claim text.